NORTHERN TRUST CORP - BIOCEPT INC ownership

BIOCEPT INC's ticker is BIOC and the CUSIP is 09072V501. A total of 26 filers reported holding BIOCEPT INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of BIOCEPT INC
ValueSharesWeighting
Q1 2023$9,118
-35.9%
26,8180.0%0.00%
Q4 2022$14,214
-43.1%
26,8180.0%0.00%
Q3 2022$25,0000.0%26,8180.0%0.00%
Q2 2022$25,000
-60.3%
26,818
-2.1%
0.00%
Q1 2022$63,000
-36.4%
27,393
+0.3%
0.00%
Q4 2021$99,000
-10.0%
27,3180.0%0.00%
Q3 2021$110,000
-6.8%
27,318
-2.6%
0.00%
Q2 2021$118,000
-17.5%
28,0470.0%0.00%
Q1 2021$143,000
+22.2%
28,047
+6.0%
0.00%
Q4 2020$117,000
-4.1%
26,459
-4.4%
0.00%
Q3 2020$122,00027,6630.00%
Other shareholders
BIOCEPT INC shareholders Q4 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 29,602$10,0650.01%
Taylor & Morgan Wealth Management, LLC 26,000$8,8400.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 94,200$32,0280.00%
Ergoteles LLC 22,020$7,4870.00%
Focused Wealth Management, Inc 1$00.00%
JANE STREET GROUP, LLC 25,403$8,6370.00%
UBS Group AG 4,412$1,5000.00%
OSAIC HOLDINGS, INC. 1,000$3400.00%
FMR LLC 40$140.00%
US BANCORP \DE\ 583$1980.00%
View complete list of BIOCEPT INC shareholders